Harvard Business Review

OCTOBER 20, 2016

As a practical matter, for example, these changes in the global policy regime are forcing multinational corporations to scale back and sell parts of their international operations. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 2, 2011

Take, for example, the debate over economic competition between China and the U.S. In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. Financial services companies co-manage loans and share risks.

Apparel 14

Apparel Pharmaceuticals Finance Licensing 14

Harvard Business Review

OCTOBER 13, 2011

Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

APRIL 16, 2012

This raises the question of whether retaining strategic cash makes economic sense and should be viewed as a legitimate corporate finance tool in today's environment. Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g.,

Company 13

Company Cost of Capital Finance Long-term 13

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. As an example of the complications ahead, let’s look at taxes. Carmakers have started using 3D technology to produce parts.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

SEPTEMBER 5, 2016

The idea isn’t new — it’s well established in online advertising, for example — but its application is becoming more widespread in the private and public sectors. Consider these examples: Education. There are management tools and incentives in place to encourage a focus on results and the end goals.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

FEBRUARY 24, 2015

For example, a divested business may inherit assets and capabilities that have been starved of investment by its former parent. Conversely, the business may be an “unpolished diamond” that was neglected by its former management for too long and whose value is just waiting to be unlocked.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

APRIL 5, 2012

Consider just a few examples. A district sales manager says: "These district sales rankings are unfair. For example: • Sales force strategy and scale. For example: • Targeting. Coaching and performance management. A regional sales director says: "The Pittsburgh territory is vacant again. Sales force deployment.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation' Executing on Innovation An HBR Insight Center. Five Ways to Innovate Faster.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. Finance Innovation Insight Center_Innovation no-intromercial' Five Ways to Innovate Faster.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MARCH 14, 2017

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

Innovation 8

Innovation Company Incentives Industry 8

Harvard Business Review

MARCH 24, 2011

What makes the matter fascinating to industry watchers, approximately their equivalent of the Charlie Sheen supernova, is that Gupta served three terms as managing director of McKinsey & Co., In his tenure as McKinsey's worldwide managing director, Gupta displayed macher-like ambition not just for himself but even more so for his firm.

McKinsey 13

McKinsey Consultative Waterman Intellectual Capital 13

Harvard Business Review

JANUARY 26, 2011

The exchange has already established listing requirements for responsibility reporting, for example. Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. After our meeting at the SSE, we had lunch with Dean Xiongwen Lu and Professor Cheng-Hua Tzeng of the Fudan School of Management.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

FEBRUARY 4, 2013

The financial crisis is a prime example of too few people holding the reins. For example, the rapidly evolving field of biomimicry examines nature's models and processes to help solve human problems. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MAY 5, 2016

sanctions are delaying these projects being financed. For example, South Korea–based LG Electronics, which maintained an Iran presence despite sanctions, is in discussions to establish a manufacturing plant in Tehran that will produce more than 1.5 However, remaining U.S. financial system for bank transactions related to Iran.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. We can and do make all of that (although not very many phones and hardly any clothing or shoes).

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

SEPTEMBER 4, 2015

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. The data captured a 20-year period, from 1995 to 2014. However, classifications were mostly clear.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

APRIL 23, 2012

Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. By any reasonable definition, pharmaceutical salespeople are absolutely salespeople. Consider this example. SmithKline Beecham Corp.

Pharmaceuticals 12

Pharmaceuticals Banking Objective Incentives 12

Harvard Business Review

JANUARY 10, 2013

For example, application of complex financial accounting rule — FAS 133 relating to derivatives — led to expensive restatements in numerous businesses. initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. billion restatement.

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

SEPTEMBER 19, 2016

You have to approach these problems as a manager and do the best analysis you can, including hard-headed financial analysis. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. But perhaps managers have no choice. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2016

We recently conducted a survey of CI managers and analysts who’ve been through our training program to see how much their findings influenced major company decisions, and why. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

JUNE 20, 2017

For example, a key source of concern for some companies is more-restrictive rules of origin, which would reduce the amount of materials allowed to be used tariff-free for products traded to and from NAFTA member countries. Multinationals are heavily pushing for either minor tweaking to the agreement or a modernization of NAFTA.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

JANUARY 4, 2017

For example, Ford’s River Rouge plant not only assembled cars but also made its own steel, glass, fabrics, power, and cement on-site. For example, Apple works with at least 200 suppliers and 242 smelters and refineries across the world. Manufacturing used to be highly vertically integrated in the U.S. We wanted to find out.

Supply Chain 8

Supply Chain Productivity Products Company 8